Treatment of the dyslipidemia of insulin resistance.
Med Clin North Am
; 91(6): 1185-210, x, 2007 Nov.
Article
em En
| MEDLINE
| ID: mdl-17964916
ABSTRACT
The increase in ischemic cardiovascular mortality and morbidity in persons with insulin resistance has been adequately documented elsewhere in this issue. Some of the most important risk factors for this increased mortality and morbidity are the lipid abnormalities, which form two out of five criteria for defining the metabolic syndrome, a definition focusing on risk factors for ischemic cardiovascular disease. This article explores the description, pathophysiology, and treatment of these atherogenic lipid abnormalities.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Resistência à Insulina
/
Inibidores de Hidroximetilglutaril-CoA Redutases
/
Dislipidemias
/
Lipídeos
/
Hipolipemiantes
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article